Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
What Hotels Don't Tell You About Hidden Fees
What Hotels Don't Tell You About Hidden Fees
Sriracha Shortage Leads to Soaring Prices
Sriracha Shortage Leads to Soaring Prices
Taylor Swift's 'Eras Tour' On Pace to Cross Billion Dollar Mark
Taylor Swift's 'Eras Tour' On Pace to Cross Billion Dollar Mark
Indiana Jones Takes Top Spot at Weekend Box Office
Indiana Jones Takes Top Spot at Weekend Box Office
Big Tobacco Posts Warning Signs, Final Step in 1999 Lawsuit
Tobacco manufacturers have started posting new warning signs about cigarettes in over 200,000 stores across the country, one of the final steps in a lawsuit filed by the Justice Department against Big Tobacco in 1999.
This Week's Top Stories: Apple Makes History, Overstock By Any Other Name & Thrift Chain IPO
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Bill in California Expected to Give Tax Break to Film and TV
Bill in California Expected to Give Tax Break to Film and TV
Nike Misses on Earnings, North America Sales Disappoint
Nike Misses on Earnings, North America Sales Disappoint
Holiday Travel Expected to Break Records as Delays and Cancellations Ease
Holiday Travel Expected to Break Records as Delays and Cancellations Ease
